Q/C TECHNOLOGIES, INC. (QCLS) Form 8-K Material Events
Q/C TECHNOLOGIES, INC. (QCLS) is a publicly traded company on the Nasdaq, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: QCLS
CIK: 1321834
Exchange: Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grassi & Co., CPAs, P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerBrendan McCarthy
Audit LocationGlastonbury, Connecticut, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-07-10 | 4 | 0001493152-26-045586 | View SEC Doc Filr Page |
| 4/A | 2026-10-02 | 2026-04-13 | 4/A | 0001493152-26-045576 | View SEC Doc Filr Page |
| 3 | 2026-09-22 | 2026-09-14 | 3 | 0001493152-26-043729 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-14 | 8-K | 0001493152-26-043401 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-10 | 8-K | 0001493152-26-042394 | View SEC Doc Filr Page |
| 3 | 2026-08-17 | 2026-08-11 | 3 | 0001493152-26-038855 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001493152-26-037333 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-26 | 8-K | 0001493152-26-031946 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001493152-26-023751 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-03-30 | 4 | 0001493152-26-023217 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-29 | 2025-12-31 | 10-K/A | 0001493152-26-019663 | View SEC Doc Filr Page |
| 4 | 2026-04-15 | 2026-04-13 | 4 | 0001493152-26-016913 | View SEC Doc Filr Page |
| 4 | 2026-04-15 | 2026-04-13 | 4 | 0001493152-26-016910 | View SEC Doc Filr Page |
| 4 | 2026-04-15 | 2026-04-13 | 4 | 0001493152-26-016914 | View SEC Doc Filr Page |
| 4 | 2026-04-15 | 2026-04-13 | 4 | 0001493152-26-016911 | View SEC Doc Filr Page |
| 4 | 2026-04-15 | 2026-04-13 | 4 | 0001493152-26-016912 | View SEC Doc Filr Page |
| 4 | 2026-04-15 | 2026-04-13 | 4 | 0001493152-26-016909 | View SEC Doc Filr Page |
| 10-K | 2026-04-15 | 2025-12-31 | 10-K | 0001493152-26-016872 | View SEC Doc Filr Page |
| NT 10-K | 2026-03-31 | 2025-12-31 | NT 10-K | 0001493152-26-014222 | View SEC Doc Filr Page |
| 8-K | 2026-03-13 | 2026-03-09 | 8-K | 0001493152-26-010070 | View SEC Doc Filr Page |
| EFFECT | 2026-02-17 | — | EFFECT Filing | 9999999995-26-000618 | View SEC Doc Filr Page |
| CORRESP | 2026-02-12 | — | CORRESP Filing | 0001493152-26-006490 | View SEC Doc Filr Page |
| S-3 | 2026-02-11 | — | S-3 | 0001493152-26-006234 | View SEC Doc Filr Page |
| 4 | 2026-01-30 | 2026-01-16 | 4 | 0001493152-26-004565 | View SEC Doc Filr Page |
| 3 | 2026-01-30 | 2026-01-16 | 3 | 0001493152-26-004564 | View SEC Doc Filr Page |